Feng Han

机构：Henan Cancer Hospital · ORCID：0000-0002-9337-7936

发表论文 107 篇 · 总被引 1587 次 · h-index 20

代表论文

• Perioperative camrelizumab plus rivoceranib versus surgery alone in patients with resectable hepatocellular carcinoma at intermediate or high risk of recurrence (CARES-009): a randomised phase 2/3 trial (2025 · The Lancet · 被引 51)
• Clinical sonochemotherapy of inoperable pancreatic cancer using diagnostic ultrasound and microbubbles: a multicentre, open-label, randomised, controlled trial (2023 · European Radiology · 被引 21)
• Development and validation of a deep learning model for predicting postoperative survival of patients with gastric cancer (2024 · BMC Public Health · 被引 17)
• Histamine-related genes participate in the establishment of an immunosuppressive microenvironment and impact the immunotherapy response in hepatocellular carcinoma (2024 · Clinical and Experimental Medicine · 被引 10)
• Combating cardiovascular disease disparities: The potential role of artificial intelligence (2025 · American Journal of Preventive Cardiology · 被引 8)
• Head and neck MRI-based T stage and [18F]FDG PET/CT-based N/M stage improved prognostic stratification in primary nasopharyngeal carcinoma (2023 · European Radiology · 被引 8)